AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Slocum, HK Parsons, JC Winslow, EO Broderick, L Minderman, H Toth, K Greco, WR Rustum, YM
Citation: Hk. Slocum et al., Time-lapse video reveals immediate heterogeneity and heritable damage among human ileocecal carcinoma HCT-8 cells treated with raltitrexed (ZD1694), CYTOMETRY, 41(4), 2000, pp. 252-260

Authors: Yin, MB Guo, B Vanhoefer, U Azrak, RG Minderman, H Frank, C Wrzosek, C Slocum, HK Rustum, YMN
Citation: Mb. Yin et al., Characterization of protein kinase chk1 essential for the cell cycle checkpoint after exposure of human head and neck carcinoma A253 cells to a noveltopoisomerase I inhibitor BNP1350, MOLEC PHARM, 57(3), 2000, pp. 453-459

Authors: Cao, SS Lu, K Toth, K Slocum, HK Shirasaka, T Rustum, YM
Citation: Ss. Cao et al., Persistent induction of apoptosis and suppression of mitosis as the basis for curative therapy with S-1, an oral 5-fluorouracil prodrug in a colorectal tumor model, CLIN CANC R, 5(2), 1999, pp. 267-274

Authors: Faessel, HM Levasseur, LM Slocum, HK Greco, WR
Citation: Hm. Faessel et al., Parabolic growth patterns in 96-well plate cell growth experiments, IN VITRO-AN, 35(5), 1999, pp. 270-278

Authors: Yin, MB Toth, K Cao, SS Guo, B Frank, C Slocum, HK Rustum, YM
Citation: Mb. Yin et al., Involvement of cyclin D1-CDK5 overexpression and MCM3 cleavage in bax-associated spontaneous apoptosis and differentiation in an A253 human head and neck carcinoma xenograft model, INT J CANC, 83(3), 1999, pp. 341-348

Authors: Yin, MB Guo, B Panadero, A Frank, C Wrzosek, C Slocum, HK Rustum, YM
Citation: Mb. Yin et al., Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex, EXP CELL RE, 247(1), 1999, pp. 189-199

Authors: Faessel, HM Slocum, HK Rustum, YM Greco, WR
Citation: Hm. Faessel et al., Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiazin-6-yl)-(S)-ethyl]-2,5-thienoylamino-L-glutamic acid (AG2034) - Comparison across sensitive and resistant human tumor cell lines, BIOCH PHARM, 57(5), 1999, pp. 567-577

Authors: Sharma, M Slocum, HK
Citation: M. Sharma et Hk. Slocum, Prevention of quinone-mediated DNA arylation by antioxidants, BIOC BIOP R, 262(3), 1999, pp. 769-774

Authors: Levasseur, LM Faessel, H Slocum, HK Greco, WR
Citation: Lm. Levasseur et al., Implications for clinical pharmacodynamic studies of the statistical characterization of an in vitro antiproliferation assay, J PHAR BIOP, 26(6), 1998, pp. 717-733

Authors: Levasseur, LM Slocum, HK Rustum, YM Greco, WR
Citation: Lm. Levasseur et al., Modeling of the time-dependency of in vitro drug cytotoxicity and resistance, CANCER RES, 58(24), 1998, pp. 5749-5761
Risultati: 1-10 |